CureVac NV (CVAC)
2.685
-0.06
(-2.19%)
USD |
NASDAQ |
Nov 14, 16:00
2.73
+0.04
(+1.68%)
After-Hours: 20:00
CureVac Shareholders Equity (Quarterly): 403.61M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 403.61M |
| March 31, 2024 | 482.62M |
| December 31, 2023 | 571.43M |
| September 30, 2023 | 637.50M |
| June 30, 2023 | 705.35M |
| March 31, 2023 | 777.92M |
| December 31, 2022 | 571.86M |
| September 30, 2022 | 614.29M |
| June 30, 2022 | 650.99M |
| Date | Value |
|---|---|
| March 31, 2022 | 753.22M |
| December 31, 2021 | 779.51M |
| September 30, 2021 | 806.47M |
| June 30, 2021 | 994.05M |
| December 31, 2020 | 874.93M |
| September 30, 2020 | 893.86M |
| March 31, 2020 | -48.15M |
| December 31, 2019 | -47.95M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-48.15M
Minimum
Mar 2020
994.05M
Maximum
Jun 2021
613.03M
Average
650.99M
Median
Jun 2022
Shareholders Equity (Quarterly) Benchmarks
| BioNTech SE | 21.35B |
| Bayer AG | 38.25B |
| Affimed NV | 30.78M |
| InflaRx NV | 88.06M |
| Immatics NV | 415.78M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 596.87M |
| Total Liabilities (Quarterly) | 193.27M |
| Current Ratio | 2.287 |